DAMBKOWSKI CARL (Chief Medical Officer) sold 2.6% of their position (5.50K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $466.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/3/2026ACC: 0001104659-26-039709
Officer· Chief Medical Officer
Since Mar 2026
-5.50K
Net shares
Net seller
$466.6K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
4.13K acquired · 9.63K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+4.13K
Price / share
$22.86
Trade value
$94.30K
% of position
2.0%
4/1/2026
209.77K→213.90K
Common Stock
Direct
Shares
−2.70K
Price / share
$84.31
Trade value
$227.47K
% of position
1.3%
4/1/2026
213.90K→211.20K
Common Stock
Direct
Shares
−2.70K
Price / share
$85.33
Trade value
$230.56K
% of position
1.3%
4/1/2026
211.20K→208.50K
Common Stock
Direct
Shares
−100.00
Price / share
$85.89
Trade value
$8.59K
% of position
0.0%
4/1/2026
208.50K→208.40K
Total
Net shares
−1.38K
Net value
-$372.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +4.13K | $22.86 | $94.30K | 2.0% | 209.77K | 213.90K |
| Common Stock Direct | 4/1/2026 | S · Sale | −2.70K | $84.31 | $227.47K | 1.3% | 213.90K | 211.20K |
| Common Stock Direct | 4/1/2026 | S · Sale | −2.70K | $85.33 | $230.56K | 1.3% | 211.20K | 208.50K |
| Common Stock Direct | 4/1/2026 | S · Sale | −100.00 | $85.89 | $8.59K | 0.0% | 208.50K | 208.40K |
| Total | −1.38K | -$372.32K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.13K shares
Shares
−4.13K
Strike price
22.86
Held after
127.17K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.13K shares | 4/1/2026 | M · Option Exercise | −4.13K | 22.86 | — | 127.17K |